Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Research Article
  • Published:

Age specific clinical manifestations and vascular involvements in childhood-onset Takayasu arteritis

Abstract

Background

Limited studies focused on characteristics of childhood-onset Takayasu arteritis (cTAK) throughout growth and development.

Methods

111 cTAK patients were recruited from six tertiary hospitals across China from January 2009 to December 2021. Patients were classified into infant group (<12 months), toddler and preschool group (≥12 months, <72 months), school-age group (≥72 months, <144 months) and adolescent group (≥144 months).

Results

Infantile cTAK patients tended to had a significantly higher proportion presenting with fever (91.7%, P-trend <0.001), and had significantly higher levels of C-reactive protein (CRP), white blood cells (WBC), platelet (PLT), and lower hemoglobin (HGB) compared to the other three groups (all P < 0.0125). Adolescent patients were more likely to present with headache (33.3%), dizziness (24.2%) and fatigue (51.5%; all P-trend < 0.001). Infantile patients were more likely to have coronary artery involvement (75.0%, P trend < 0.001). Adolescent patients were more likely to have superior mesenteric artery (36.4%, P trend = 0.005), carotid artery (30.3%, P trend = 0.003), and celiac trunk artery stenosis (27.3%, P trend = 0.005).Younger patients, especially infants, had a lower proportion of glucocorticoids use (P trend = 0.001). 73.0% (81/111) of patients were in remission, with a median follow-up time of 2.00 [2.00, 5.00] years.

Conclusion

The age-specific patterns identified in this study offered valuable insights for a comprehensive understanding of cTAK.

Impact

  • Infantile Takayasu arteritis patients tended to present with fever, elevated inflammatory biomarkers and coronary artery involvement. Adolescent patients were more likely to present with headache, dizziness and fatigue, with superior mesenteric artery, carotid artery involvement and celiac trunk artery stenosis.

  • Clinical manifestations and vascular involvement of childhood-onset Takayasu arteritis differ across age groups.

  • The clinical manifestations of childhood-onset Takayasu arteritis lack specificity. The age-specific patterns identified in this study may provide clues for early diagnosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flow chart.

Similar content being viewed by others

Data availability

The dataset analyzed for the current study is available from the corresponding author upon reasonable request.

References

  1. Maz, M. et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. 73, 1349–1365 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kerr, G. S. et al. Takayasu Arteritis. Ann. Intern Med. 120, 919–929 (1994).

    Article  CAS  PubMed  Google Scholar 

  3. Fan, L. et al. Clinical scenario and long-term outcome of childhood Takayasu Arteritis undergoing 121 endovascular interventions: a large cohort over a Fifteen-Year Period. Arthritis Care Res. 73, 1678–1688 (2021).

    Article  Google Scholar 

  4. Hassold, N. et al. Clinical spectrum and outcome of Takayasu’s Arteritis in Children. Jt. Bone Spine 91, 105735 (2024).

    Article  Google Scholar 

  5. Rathore, U., Chandwar, K., Singh, K. & Misra, D. P. Pediatric-onset Takayasu Arteritis is associated with greater risk of mortality than adult-onset Takayasu Arteritis-a systematic review with meta-analysis of observational Cohort studies. Semin. Arthritis Rheum. 65, 152355 (2024).

    Article  PubMed  Google Scholar 

  6. Misra, D. P. et al. Paediatric-onset Takayasu’s Arteritis associates with worse survival than adult-onset Takayasu’s Arteritis. A matched retrospective cohort Study. Clin. Exp. Rheumatol. 42, 914–922 (2024).

    PubMed  Google Scholar 

  7. Ishikawa, K. & Maetani, S. Long-term outcome for 120 Japanese patients with Takayasu’s disease. clinical and statistical analyses of related prognostic factors. Circulation 90, 1855–1860 (1994).

    Article  CAS  PubMed  Google Scholar 

  8. Ren, X. et al. Assessment of coronary involvement with Mdct and long-term outcomes in patients with Takayasu’s arteritis. Acad. Radio. 31, 4329–4339 (2024).

    Article  Google Scholar 

  9. Zhao, X. et al. Clinical characteristics, treatment, and outcome of 43 cases of infant-onset Takayasu Arteritis. Indian J. Pediatr. 90, 416 (2023).

    Article  PubMed  Google Scholar 

  10. Miller-Barmak, A. et al. Infantile Takayasu: clinical features and long-term outcome. Rheumatology 62, 3126–3132 (2023).

    Article  CAS  PubMed  Google Scholar 

  11. Jin, J. et al. A retrospective study of infantile-onset Takayasu Arteritis: experience from a tertiary referral center in China. Front. Cardiovasc. Med. 11, 1249305 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Pavić, R., Blažeković, R., Divković, D., Marjanović, K. & Sipl, M. Aggressive progression of Takayasu’s Arteritis in infancy: a case report. Acta Clin. Croat. 58, 535–539 (2019).

    PubMed  PubMed Central  Google Scholar 

  13. Liu, H., Sun, L., Upadhyaya, R. S., Chen, Y. & Ajoje, O. O. Case report: Takayasu Arteritis in a 3-month-old Chinese Girl. Medicine 97, e12637 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wang, E. L., Sato, Y., Takeichi, T. & Kitamura, O. Sudden death of an infant with coronary involvement due to Takayasu Arteritis. Cardiovasc. Pathol. 22, 109–111 (2013).

    Article  CAS  PubMed  Google Scholar 

  15. Clemente, G. et al. Takayasu Arteritis in childhood: misdiagnoses at disease onset and associated diseases. Rheumatol. Int. 38, 1089–1094 (2018).

    Article  CAS  PubMed  Google Scholar 

  16. Ozen, S. et al. Eular/Printo/Pres Criteria for Henoch-Schönlein Purpura, Childhood Polyarteritis Nodosa, Childhood Wegener Granulomatosis and Childhood Takayasu Arteritis: Ankara 2008. Part Ii: Final Classification Criteria. Ann. Rheum. Dis. 69, 798–806 (2010).

    Article  PubMed  Google Scholar 

  17. Arend, W. P. et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu Arteritis. Arthritis Rheum. 33, 1129–1134 (1990).

    Article  CAS  PubMed  Google Scholar 

  18. Lupi-Herrera, E. et al. Takayasu’s Arteritis. Clinical Study of 107 Cases. Am. Heart J. 93, 94–103 (1977).

    Article  CAS  PubMed  Google Scholar 

  19. McCrindle, B. W. et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the american heart association. Circulation 135, e927–e999 (2017).

    Article  PubMed  Google Scholar 

  20. Misra, D. P. et al. Presentation and clinical course of pediatric-onset versus adult-onset Takayasu Arteritis-a systematic review and meta-analysis. Clin. Rheumatol. 41, 3601–3613 (2022).

    Article  PubMed  Google Scholar 

  21. Karabacak, M. et al. Childhood-onset versus adult-onset Takayasu Arteritis: a study of 141 patients from Turkey. Semin. Arthritis Rheum. 51, 192–197 (2021).

    Article  PubMed  Google Scholar 

  22. Danda, D. et al. Clinical course of 602 patients with Takayasu’s Arteritis: comparison between childhood-onset versus adult onset disease. Rheumatology60, 2246–2255 (2021).

    Article  CAS  PubMed  Google Scholar 

  23. Cong, X. L. et al. Takayasu’s Arteritis: clinical features and outcomes of 125 patients in China. Clin. Rheumatol. 29, 973–981 (2010).

    Article  PubMed  Google Scholar 

  24. Clemente, G. et al. Brazilian multicenter study of 71 patients with juvenile-onset Takayasu’s Arteritis: clinical and angiographic features. Rev. Bras. Reumatol. Engl. Ed. 56, 145–151 (2016).

    Article  PubMed  Google Scholar 

  25. Peremans, L. et al. Real-World Biomarkers for Pediatric Takayasu Arteritis. Int. J. Mol. Sci. 25, 7345 (2024).

  26. Kong, F., Xu, Y., Huang, X., Lai, J. & Zhao, Y. Childhood-onset versus adult-onset Takayasu Arteritis: a study of 239 patients from China. Jt. Bone Spine 92, 105806 (2024).

    Article  Google Scholar 

  27. Pérez-Pomares, J. M. et al. Congenital coronary artery anomalies: a bridge from embryology to anatomy and pathophysiology-a position statement of the development, anatomy, and pathology Esc Working Group. Cardiovasc. Res. 109, 204–216 (2016).

    Article  PubMed  Google Scholar 

  28. Xu, Y. et al. Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu Arteritis patients: a retrospective study. Pediatr. Rheumatol. Online J. 21, 42 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  29. Maccora, I. et al. Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome. Eur. J. Pediatr. 180, 271–275 (2021).

    Article  PubMed  Google Scholar 

  30. Jia, W. et al. Decreased absolute number of circulating regulatory T cells in patients with Takayasu’s Arteritis. Front. Immunol. 12, 768244 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Watanabe, R., Berry, G. J., Liang, D. H., Goronzy, J. J. & Weyand, C. M. Pathogenesis of giant cell arteritis and Takayasu Arteritis-similarities and differences. Curr. Rheumatol. Rep. 22, 68 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zhao, Q. M. et al. Systemic artery Aneurysms and Kawasaki disease. Pediatrics 144, e20192254 (2019).

  33. Burns, J. C. et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (Kidcare): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc. Health 5, 852–861 (2021).

    Article  CAS  PubMed  Google Scholar 

  34. Wang, Z. et al. Methylprednisolone pulse therapy or additional Ivig for patients with Ivig-Resistant Kawasaki disease. J. Immunol. Res. 2020, 4175821 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  35. Eleftheriou, D. et al. Takayasu Arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res. Ther. 17, 36 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  36. Sener, S. et al. Treatment of childhood-onset Takayasu Arteritis: switching between Anti-Tnf and Anti-Il-6 Agents. Rheumatology61, 4885–4891 (2022).

    Article  CAS  PubMed  Google Scholar 

  37. Aeschlimann, F. A. et al. Childhood Takayasu Arteritis: disease course and response to therapy. Arthritis Res. Ther. 19, 255 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Stern, S. et al. Treatment of Pediatric Takayasu Arteritis with Infliximab and cyclophosphamide: experience from an American-Brazilian Cohort Study. J. Clin. Rheumatol. 20, 183–188 (2014).

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by Beijing Research Ward Excellence Program (BRWEP2024W102100100).

Author information

Authors and Affiliations

Contributions

Y.X., C.W., X.L., and J.L. conceived the study. M.K., J.Z., F.L., B.H., W.C., L.W., X.Z., G.S., D.Z., T.Y, and M.L. contributed to patient management. Y.X. and J.L. supervised patient management. YT and ML collected data. Y.X., C.W., and W.N. contributed to methodology. C.W. and W.N. performed the data analysis. Y.X. and C.W. wrote the first draft of the manuscript. X.L. and J.L. critically revised the manuscript. All the authors approved the final version of the manuscript submitted for publication and agree to be accountable for all aspects of the work.

Corresponding authors

Correspondence to Jianming Lai or Xiaohui Li.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval and consent to participate

This study was approved by the Ethics Committee of the Capital Institute of Pediatrics (SHERLLM 2021051). Written informed consents obtained from patients or guardians.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Y., Wang, C., Niu, W. et al. Age specific clinical manifestations and vascular involvements in childhood-onset Takayasu arteritis. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04424-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41390-025-04424-z

This article is cited by

Search

Quick links